BRPI0507384A - pró-droga glicosìdica de ácido 5-aminossalicìlico - Google Patents

pró-droga glicosìdica de ácido 5-aminossalicìlico

Info

Publication number
BRPI0507384A
BRPI0507384A BRPI0507384-7A BRPI0507384A BRPI0507384A BR PI0507384 A BRPI0507384 A BR PI0507384A BR PI0507384 A BRPI0507384 A BR PI0507384A BR PI0507384 A BRPI0507384 A BR PI0507384A
Authority
BR
Brazil
Prior art keywords
asa
large intestine
aminosalicylic acid
medicine
glycosidically
Prior art date
Application number
BRPI0507384-7A
Other languages
English (en)
Inventor
Akio Nakamura
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of BRPI0507384A publication Critical patent/BRPI0507384A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/04—Monocyclic monocarboxylic acids
    • C07C63/06—Benzoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

PRó-DROGA GLICOSìDICA DE áCIDO 5-AMINOSSALICìLICO. A presente invenção refere-se a um medicamento para colite ulcerativa por meio do qual ácido 5-aminossalicílico (5-ASA) útil como medicamento para colite ulcerativa pode ser eficientemente distribuido para o local afetado (isto é, o intestino grosso) com pouca absorção ou metabolismo no estómago ou na parte superior do instestino delgado e que é altamente seguro e pode ser administrado por um longo período de tempo. A saber, 5-ASA contendo D-galactose introduzida no mesmo que é representada pela fórmula geral ¢1! a seguir. ¢1} Este composto pode chegar ao local de função (isto é, o intestino grosso) com eficiência. Em seguida a flora intestinal o decompõe para então formar 5-ASA que é o ingrediente ativo no intestino grosso.
BRPI0507384-7A 2004-02-03 2005-02-02 pró-droga glicosìdica de ácido 5-aminossalicìlico BRPI0507384A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004026916 2004-02-03
PCT/JP2005/001492 WO2005075492A1 (ja) 2004-02-03 2005-02-02 ５−アミノサリチル酸の配糖体プロドラッグ

Publications (1)

Publication Number Publication Date
BRPI0507384A true BRPI0507384A (pt) 2007-07-10

Family

ID=34835875

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507384-7A BRPI0507384A (pt) 2004-02-03 2005-02-02 pró-droga glicosìdica de ácido 5-aminossalicìlico

Country Status (10)

Country Link
US (1) US20070173461A1 (pt)
EP (1) EP1712555A4 (pt)
JP (1) JPWO2005075492A1 (pt)
KR (1) KR20060129038A (pt)
CN (1) CN1914220A (pt)
AU (1) AU2005210299A1 (pt)
BR (1) BRPI0507384A (pt)
CA (1) CA2554091A1 (pt)
RU (1) RU2341529C2 (pt)
WO (1) WO2005075492A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101863934B (zh) * 2009-04-20 2014-07-23 中国医学科学院药物研究所 水杨酸甲酯糖苷类化合物、其合成方法与用途
MD480Z5 (ro) * 2011-07-07 2012-09-30 Эльвира АНДОН Metodă de tratament al colitei ulceroase nespecifice acute
GB2493712B (en) 2011-08-12 2014-07-02 Gene Onyx Ltd Insulin pump
CN103254257A (zh) * 2013-04-18 2013-08-21 山西医科大学 一种4-氨基水杨酸糖苷类衍生物及其制备方法
JP2020522514A (ja) * 2017-06-05 2020-07-30 フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド マルチバイオティック剤及びその使用方法
EP3801489A4 (en) 2018-06-05 2022-03-30 Flagship Pioneering Innovations V, Inc. ACYLATED DRUGS AND METHODS OF USE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
GB201904758D0 (en) * 2019-04-04 2019-05-22 Univ British Columbia Xyloglucan-containing prodrugs and methods of manufacture and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5924966B2 (ja) * 1978-12-29 1984-06-13 呉羽化学工業株式会社 アミノ安息香酸誘導体又はその医薬上許容される塩を有効成分とする抗炎症剤
JPS60501105A (ja) * 1983-04-14 1985-07-18 ザ　・レ−ゲンツ・オブ・ザ・ユニバ−シティ・オブ・カリフォルニヤ 結腸特異性の薬剤付与系
DE3323702A1 (de) * 1983-07-01 1985-01-10 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin 5-aminosalicylsaeure-o-sulfate von physiologisch unbedenklichen basen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
US20070173461A1 (en) 2007-07-26
CN1914220A (zh) 2007-02-14
RU2006131594A (ru) 2008-03-10
WO2005075492A1 (ja) 2005-08-18
RU2341529C2 (ru) 2008-12-20
EP1712555A1 (en) 2006-10-18
CA2554091A1 (en) 2005-08-18
EP1712555A4 (en) 2008-04-02
KR20060129038A (ko) 2006-12-14
JPWO2005075492A1 (ja) 2007-10-11
AU2005210299A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
BR0014441A (pt) Composições que apresentam estabilidade aperfeiçoada
BR9914932A (pt) Processo para a manufatura de uma composição de isotretinoìna, composição de isotretinoìna micronizada, forma de dosagem unitária para administração enteral e composição farmacêutica na forma de dosagem unitária
Crouthamel et al. Drug absorption IV: Influence of pH on absorption kinetics of weakly acidic drugs
BRPI0507384A (pt) pró-droga glicosìdica de ácido 5-aminossalicìlico
BRPI0412059A (pt) método para a preparação de formulação de liberação controlada
BRPI0417947A (pt) composto, composição farmacêutica, fabricação de um medicamento para o uso no tratamento e/ou prevenção de um metabólico distúrbio, e, formulação farmacêutica
AR006569A1 (es) Derivados de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion
MX9307781A (es) Derivados de acidos carboxilicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion.
BRPI0520493A2 (pt) usos de uma enzima, de um composto antifolato e de um agente de resgate de rota de folato, sistema terapêutico, e, métodos ex vivo para clivar um grupo l-glutamato terminal de um composto, para determinar a taxa e/ou extensão de clivagem de um composto e para clivar um composto
BRPI0515982A (pt) medicamento e sistema para a preparação percutánea de medicamentos
AR070869A1 (es) Acidos dicarboxilicos de cadena media, sus derivados para tratar desordenes metabolicos
BR0317340A (pt) Formulações de hfc em solução contendo tiotrópio
BR9808521A (pt) Moléculas que apresentam um grande número de partes ativas.
BR0308316A (pt) Sais de nateglinida
BRPI0408240A (pt) composto, utilização de um composto e composição farmacêutica
NO20084478L (no) Konjugerte lipidderivater
AR005468A1 (es) Nuevos derivados de benzoilguanidina, procedimientos para su preparacion y su empleo en la preparacion de medicamentos.
BR9915729A (pt) Amidas Èmega de n-arilsulfonil-aminoácido
Altınterim Effects of willow bark salix alba and its salicylates on blood coagulant
ES2040307T3 (es) Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.
Yan et al. Role of nitric oxide in ethanol-induced ascorbic acid release in striatum of freely moving mice
TH93865A (th) สารผสมแลนธานัม คาร์บอเนทที่ถูกทำให้เสถียร
Wright et al. Urticaria and hidden salicylates
BRPI0404732A (pt) processo para produção de conservante quìmico em forma de comprimidos para a conservação e leite e outros produtos
TW200600094A (en) Pharmaceutical compositions for prevention or treatment of disorders of lipid metabolism

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A E 6A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2099 DE 29/03/2011.